BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 11406922)

  • 21. Vascular dementia: distinguishing characteristics, treatment, and prevention.
    Román GC
    J Am Geriatr Soc; 2003 May; 51(5 Suppl Dementia):S296-304. PubMed ID: 12801386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular dementia and Alzheimer's disease: the unsolved problem of clinical and neuropsychological differential diagnosis.
    Misciagna S; Masullo C; Giordano A; Silveri MC
    Int J Neurosci; 2005 Dec; 115(12):1657-67. PubMed ID: 16287632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of vascular dementia in India: study of clinical features, imaging, and vascular mechanisms from a hospital dementia registry.
    Alladi S; Kaul S; Meena AK; Somayajula S; Umadevi M; Reddy JM
    J Stroke Cerebrovasc Dis; 2006; 15(2):49-56. PubMed ID: 17904048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meeting the challenges of vascular dementia. Introduction.
    Small G
    Int J Clin Pract Suppl; 2001 May; (120):1-4. PubMed ID: 11406921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular cognitive impairment.
    Selnes OA; Vinters HV
    Nat Clin Pract Neurol; 2006 Oct; 2(10):538-47. PubMed ID: 16990827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS; Huang J; Chowdhury MH
    J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychological aspects of vascular dementia.
    McPherson SE; Cummings JL
    Brain Cogn; 1996 Jul; 31(2):269-82. PubMed ID: 8812007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical diagnosis of vascular dementia: A comparison among four classification systems and a proposal for a new paradigm.
    Cosentino SA; Jefferson AL; Carey M; Price CC; Davis-Garrett K; Swenson R; Libon DJ
    Clin Neuropsychol; 2004 Feb; 18(1):6-21. PubMed ID: 15595354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and treatment of mixed dementia].
    Hanyu H
    Brain Nerve; 2012 Sep; 64(9):1047-55. PubMed ID: 22941841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular lesions in mixed dementia, vascular dementia, and Alzheimer disease with cerebrovascular disease: the Kurihara Project.
    Meguro K; Tanaka N; Nakatsuka M; Nakamura K; Satoh M
    J Neurol Sci; 2012 Nov; 322(1-2):157-60. PubMed ID: 22871542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment in dementia: correlations with atrophy and cerebrovascular disease quantified by magnetic resonance imaging.
    Swartz RH; Black SE; Sela G; Bronskill MJ
    Brain Cogn; 2002 Jul; 49(2):228-32. PubMed ID: 15259397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vascular dementia: the dubious disease].
    Derouesné C
    Psychol Neuropsychiatr Vieil; 2005 Jun; 3(2):89-96. PubMed ID: 15929922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage-independent and stage-specific phenotypic differences between vascular dementia and Alzheimer's Disease.
    Chan M; Lim WS; Sahadevan S
    Dement Geriatr Cogn Disord; 2008; 26(6):513-21. PubMed ID: 19052451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive deficits in preclinical Alzheimer's disease and vascular dementia: patterns of findings from the Kungsholmen Project.
    Bäckman L; Small BJ
    Physiol Behav; 2007 Sep; 92(1-2):80-6. PubMed ID: 17573076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology.
    Zekry D; Duyckaerts C; Belmin J; Geoffre C; Moulias R; Hauw JJ
    J Neurol; 2002 Nov; 249(11):1529-34. PubMed ID: 12420093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Does magnetization transfer ratio (MTR) contribute to the diagnosis and differential diagnosis of the dementias?].
    Hentschel F; Kreis M; Damian M; Krumm B
    Rofo; 2004 Dec; 176(12):1743-9. PubMed ID: 15573284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trials of propentofylline in vascular dementia. European/Canadian Propentofylline Study Group.
    Kittner B
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S166-71. PubMed ID: 10609697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of memory impairment and perseverative behavior discriminate early Alzheimer's disease from subcortical vascular dementia.
    Traykov L; Baudic S; Raoux N; Latour F; Rieu D; Smagghe A; Rigaud AS
    J Neurol Sci; 2005 Mar; 229-230():75-9. PubMed ID: 15760623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric manifestations in vascular cognitive impairment patients with and without dementia.
    Chiu PY; Liu CH; Tsai CH
    Acta Neurol Taiwan; 2007 Jun; 16(2):86-91. PubMed ID: 17685132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.